image for newsletter
A weekly summary of the news, trends, reviews, profiles and articles from Pharma Tech Outlook
January 17, 2019

Pharma Tech Outlook Weekly Brief

Newsletter for Enterprise Technology Decision Makers

Feature of the Week
Biopharmaceutical development is entering a new phase with advanced classes of treatments that are harnessing the natural power of viruses and cells and maneuvering them to fight human diseases.
Implementation of automation has increased the efficiency of operation theaters. It allows more time to assist post-surgery patients before having prepare for the next surgical procedure.
The folklore reveres the royal jelly as a form of super medicines, in Europe and Asia, royalactin's DNA sequence, which is the active component of the jelly, has been uniquely identified to be honeybees.
Featured Vendors
Develops and provides cloud-based solutions designed to meet the challenges of scientific and R&D data management.
One of the leading drug development advisory firms specialized in Quantitative Systems Pharmacology.
Provides diagnostic decision support platform enabling clinicians to interrogate genomes to identify disease-causing variants.
CIO Viewpoint
Greg Woff, CIO, University of Massachusetts Medical School
Changing strategic course is what CIO's are required to do, and this turn of IT's rudder may help improve healthcare at a critical juncture.
Mark Crandall, MD, CIO, Consulate Health CareSystem
As a national leading provider of senior healthcare services to 150 care centers in 15 states, Consulate Health Care has grown with a strong focus on patient needs.
CXO Insights
By Matt Bakaitis, Director, Cleveland Clinic
At Cleveland Clinic, we have the motto "Patients First". When planning marketing efforts, the motto is powerful.
By Christian Burns, Director of Clinical Operations and Patient Recruitment, ClinEdge
The clinical research industry is witnessing a shift in how sponsors, research clinics, and patients collaborate.